Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion | Scientific Reports
Time to Resolution of Diabetic Macular Edema after Treatment with Intravitreal Aflibercept Injection or Laser in VISTA and VIVID - Ophthalmology Retina
Is It Time to Treat Presymptomatic DR?
Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema | SpringerLink
Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema | Scientific Reports
One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision - Ophthalmology Retina
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry - ScienceDirect
Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study | Scientific Reports
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial | BMC
Intravitreal administration - Wikipedia
Intravitreal Steriod Injections for Macular Edema
Intravitreal Therapy for Diabetic Macular Edema: An Update
Intravitreal Anti-VEGF Injection Treatment Algorithms for DME - Retina Today
Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema - Mayo Clinic
Retinal Physician - Addressing Myths of Diabetic Macular Edema Treatment
A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema - Ophthalmology
JCM | Free Full-Text | Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems | HTML
Optimal Dose and Cost-effectiveness of Ranibizumab Treatment of Diabetic Macular Oedema - touchOPHTHALMOLOGY
Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland | SpringerLink
IVT Injections: Health Policy Implications
Effects of Intravitreal Injection on Ocular Surface and Anterior Segment Parameters
Novel therapeutic targets in diabetic macular edema: Beyond VEGF - ScienceDirect
Cells | Free Full-Text | Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options | HTML
